CXHS0503398 | 1,4-丁烷二磺酸腺苷蛋氨酸 | | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2006-02-07 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2008-11-05 | view |
CXSL2300038 | KW-027注射液 | KW-027 | Injection | Biological Products(1) | New Drug Application | 2023-01-13 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
CXHL1401836 | KW-136 | coblopasvir hydrochloride | Other | Chemical Drugs(1.1) | New Drug Application | 2015-01-04 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2016-05-05 | view |
CXHL1600290 | KW-136片 | coblopasvir hydrochloride | Tablet | Chemical Drugs(1) | New Drug Application | 2017-04-13 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2017-11-30 | view |
CXHL1600291 | KW-136片 | coblopasvir hydrochloride | Tablet | Chemical Drugs(1) | New Drug Application | 2017-04-13 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2017-11-30 | view |
CXHL1401837 | KW-136胶囊 | coblopasvir hydrochloride | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-01-04 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2016-05-05 | view |
CXHS1800007 | KW-136胶囊 | coblopasvir hydrochloride | Capsule | Chemical Drugs(1) | New Drug Application | 2018-06-22 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-02-14 | view |
CXHL1401838 | KW-136胶囊 | coblopasvir hydrochloride | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-01-04 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2016-05-05 | view |
CXSL2000361 | XW003注射液 | ecnoglutide | Injection | Biological Products(1) | New Drug Application | 2020-12-16 | 杭州先为达生物科技有限公司;北京凯因科技股份有限公司 | | In Review | 2020-12-15 | view |
CYHS1001028 | 丁二磺酸腺苷蛋氨酸 | ademetionine | Active ingredient | Chemical Drugs(6) | Generic Drug | 2011-09-14 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2017-01-23 | view |
CYHS1300467 | 丁二磺酸腺苷蛋氨酸肠溶片 | ademetionine | Tablet | Chemical Drugs(6) | Generic Drug | 2014-01-07 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2016-09-26 | view |
CXSL2200459 | 人干扰素α2b喷雾剂 | Recombinant Human Interferon α2b | Spray | Biological Products(2.2) | New Drug Application | 2022-09-14 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
CYSB2400272 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-10-15 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
CYSB2400273 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-10-15 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
CYSB2400271 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-10-15 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
CYSB2200184 | 人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products | Supplementary Application | 2022-07-28 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
CXSL2400018 | 人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products(2.2) | New Drug Application | 2024-01-10 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
CXSL2400016 | 人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products(2.2) | New Drug Application | 2024-01-09 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
CXHL0700114 | 匹多莫德注射液 | pidotimod | Injection | Chemical Drugs(2) | New Drug Application | 2007-10-31 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2009-02-12 | view |
CXHS1400042 | 吡非尼酮片 | pirfenidone | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-06-27 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2016-01-21 | view |